Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Patient-reported outcome assessment of inflammatory arthritis patient experience with intravenously administered biologic therapy.

Gaylis NB, Sagliani J, Black S, Tang KL, DeHoratius R, Kafka WA, Parenti D.

Patient Prefer Adherence. 2017 Sep 12;11:1543-1553. doi: 10.2147/PPA.S136567. eCollection 2017.

2.

Safety of infusing rituximab at a more rapid rate in patients with rheumatoid arthritis: results from the RATE-RA study.

Pritchard CH, Greenwald MW, Kremer JM, Gaylis NB, Rigby W, Zlotnick S, Chung C, Jaber B, Reiss W; RATE-RA Study Group.

BMC Musculoskelet Disord. 2014 May 24;15:177. doi: 10.1186/1471-2474-15-177.

3.

The value of magnetic resonance imaging in clinical practice.

Gaylis NB.

J Clin Rheumatol. 2014 Jun;20(4):211-4. doi: 10.1097/RHU.0000000000000113. No abstract available.

PMID:
24847748
4.

Monitoring cartilage loss in the hands and wrists in rheumatoid arthritis with magnetic resonance imaging in a multi-center clinical trial: IMPRESS (NCT00425932).

Peterfy CG, Olech E, DiCarlo JC, Merrill JT, Countryman PJ, Gaylis NB.

Arthritis Res Ther. 2013 Mar 20;15(2):R44. doi: 10.1186/ar4202.

5.

Long-term follow-up of an HIV-infected patient with reactive arthritis treated with infliximab.

Gaylis NB.

J Clin Rheumatol. 2012 Apr;18(3):153-4. doi: 10.1097/RHU.0b013e31824e9151. No abstract available.

PMID:
22426582
6.

Retreatment with rituximab based on a treatment-to-target approach provides better disease control than treatment as needed in patients with rheumatoid arthritis: a retrospective pooled analysis.

Emery P, Mease PJ, Rubbert-Roth A, Curtis JR, Müller-Ladner U, Gaylis NB, Williams S, Reynard M, Tyrrell H.

Rheumatology (Oxford). 2011 Dec;50(12):2223-32. doi: 10.1093/rheumatology/ker253. Epub 2011 Sep 16.

7.

Magnetic resonance imaging in rheumatoid arthritis clinical trials: emerging patterns based on recent experience.

Peterfy CG, Countryman P, Gabriele A, Shaw T, Anisfeld A, Tsuji W, Olech E, Gaylis NB, Conaghan PG, Strand V, Dicarlo J.

J Rheumatol. 2011 Sep;38(9):2023-30. doi: 10.3899/jrheum.110418.

PMID:
21885511
8.

Efficacy and safety of retreatment in patients with rheumatoid arthritis with previous inadequate response to tumor necrosis factor inhibitors: results from the SUNRISE trial.

Mease PJ, Cohen S, Gaylis NB, Chubick A, Kaell AT, Greenwald M, Agarwal S, Yin M, Kelman A.

J Rheumatol. 2010 May;37(5):917-27. doi: 10.3899/jrheum.090442. Epub 2010 Mar 1.

PMID:
20194448
9.

In-office magnetic resonance imaging to monitor responses to therapy in rheumatoid arthritis.

Gaylis NB, Needell SD.

Rheumatol Int. 2009 Dec;30(2):269-73. doi: 10.1007/s00296-009-0927-2.

PMID:
19387648
11.
12.

The selective value of computed tomography of the brain in cerebritis due to systemic lupus erythematosus.

Gaylis NB, Altman RD, Ostrov S, Quencer R.

J Rheumatol. 1982 Nov-Dec;9(6):850-4.

PMID:
7161775
13.

Cerebral atrophy in systemic lupus erythematosus: steroid- or disease-induced phenomenon?

Ostrov SG, Quencer RM, Gaylis NB, Altman RD.

AJNR Am J Neuroradiol. 1982 Jan-Feb;3(1):21-3.

PMID:
6800237
14.

Bacterial monarthritis due to Neisseria meningitidis in systemic lupus erythematosus.

Schenfeld L, Gray RG, Poppo MJ, Gaylis NB, Gottlieb NL.

J Rheumatol. 1981 Jan-Feb;8(1):145-8.

PMID:
7218243

Supplemental Content

Loading ...
Support Center